Low-level vancomycin resistance was observed for 28 clinical Clostridium innocuum
isolates and C. innocuum NCIB 10674, whereas teicoplanin was active. DNA from three …

Acquired vancomycin resistance in Gram-positive anaerobes has been reported only in
Australia and Canada from rare vanB-positive stool samples in the absence of vancomycin …

Objectives Extra-intestinal clostridial infection (EICI) is rare but can be fatal. Traditional
phenotypic methods can only assign many of the Clostridium species to the genus level …

Objectives The objective was to study a new vanG-type locus in Clostridium argentinense
vanGCar and to determine its impact on glycopeptide susceptibility of the host. Methods The …

We have studied the basis for intrinsic resistance to low levels of vancomycin in Clostridium
innocuum NCIB 10674 (MIC= 8 μg/ml). Analysis by high-pressure liquid chromatography …

An 85 year-old male initially admitted for septic shock due to urinary tract infection
experienced Clostridium difficile-associated diarrhea during hospitalization and was treated …

Objectives: During a hospital surveillance programme to detect VRE carriers, an anaerobic
vancomycin-resistant bacterial strain CCRI-9842 containing a vanB gene was isolated from …

Vancomycin resistance Vancomycin therapy has become more widespread in re-cent years,
cspccially in areas with a high prevalence of methicillin-resistant staphylococci. Increased …

During investigation of an outbreak of vancomycin resistant Enterococcus faecium in a
paediatric hospital, an isolate of Enterococcus durans resistant to vancomycin, teicoplanin …

The glycopeptide antibiotic vancomycin is an effective agent for treating infections caused by
gram-positive cocci and bacilli. Vancomycin binds to peptides containing D-alanyl-D …